Randomized Trialhigh evidence

Melatonin for neuropathic pain: a double-blind, placebo-controlled, randomized, crossover trial.

Pain·November 1, 2025·PMID 40359364

Why it matters

Neuropathic pain is often worse at night and associated with sleep disturbance, and safe nonopioid treatments are needed. Despite preclinical and observational signals suggesting melatonin might reduce pain, this well-designed trial found no analgesic benefit over placebo, helping clinicians avoid ineffective therapy.

Infographic summary of Melatonin for neuropathic pain: a double-blind, placebo-controlled, randomized, crossover trial.
Visual abstract · MedLit

The papers that matter, first.

MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.

§

MedLit · Evidence, Distilled